Effectiveness of metabolic modulation in treating post-vaccination syndrome: study protocol for a prospective and randomized controlled trial
DOI:
https://doi.org/10.18203/2349-3259.ijct20260046Keywords:
Post-acute COVID-19 syndrome, Metabolic modulation, Spike protein, Nutraceuticals, Supplement protocolAbstract
Background: Post-acute COVID-19 vaccination syndrome (PACVS) emerged as a rare complication of the COVID-19 vaccination campaigns, which began in late 2020, when the first trials were underway, and continued to the present day, when COVID-19 vaccines are available for use. While their uptake peaked in the years of 2021 and 2022, a rare side-effect was the presence of a myalgic encephalitis/chronic fatigue syndrome (ME/CFS) phenotype. This population has limited treatment options available, and surveys show that many are trying poorly validated treatment protocols with limited success.
Methods: One hundred patients presenting with PACVS with a lab-confirmed diagnosis will be enrolled for a 3-month study. Patients are randomized to intervention and placebo groups and provided with a combined metabolic modulator, called ViTAL SCAN (vitamin C, taurine, acetyl L-carnitine, serine/sarcosine, creatine/citrulline, acetylcysteine/ arginine, and NMN) in the intervention group, and unflavoured rice protein powder with vitamin C in the placebo group. Baseline measurements of a combined biomarker panel, including metabolic and inflammatory markers, as well as heart rate variability, physical performance, and self-rated quality of life.
Conclusions: Treatment of PACVS currently has a lack of evidence for the efficacy of treatment interventions for the disease. While several interventions have been proposed, their prospective clinical usefulness relies on arguments from mechanism or analogy from related disorders (e.g., long COVID-19, ME/CFS, acute COVID-19 infection). Limited data exists on the clinical efficacy of treatments for PACVS. This research proposal tests a combined nutraceutical for the purpose of improving metabolic parameters.
Trial Registration: Clinical Trials Gov NCT number will be obtained.
Metrics
References
Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med. 2021;7:606824. DOI: https://doi.org/10.3389/fmed.2020.606824
Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)—a systemic review and comparison of clinical presentation and symptomatology. Medicina (Mex). 2021;57(5):418. DOI: https://doi.org/10.3390/medicina57050418
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-46. DOI: https://doi.org/10.1038/s41579-022-00846-2
Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. DOI: https://doi.org/10.3389/fmicb.2021.698169
Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clin Infect Dis. 2023;76(3):e487-90. DOI: https://doi.org/10.1093/cid/ciac722
Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care. 2021;10(2):51-80. DOI: https://doi.org/10.1089/wound.2020.1309
Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881-95. DOI: https://doi.org/10.1016/j.cell.2022.01.014
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737-54. DOI: https://doi.org/10.1080/23744235.2021.1924397
Krumholz HM, Wu Y, Sawano M, Shah R, Zhou T, Arun AS, et al. Post-Vaccination Syndrome: A Descriptive Analysis of Reported Symptoms and Patient Experiences After Covid-19 Immunization. medRxiv. 2023;2023:23298266. DOI: https://doi.org/10.1101/2023.11.09.23298266
CDC. IOM 2015 Diagnostic Criteria. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 2024. Available at: https://www.cdc.gov/me-cfs/hcp/diagnosis/iom-2015-diagnostic-criteria-1.html. Accessed on 25 October 2025.
Blachier F, Blais A, Elango R, Saito K, Shimomura Y, Kadowaki M, et al. Tolerable amounts of amino acids for human supplementation: summary and lessons from published peer-reviewed studies. Amino Acids. 2021;53(9):1313-28. DOI: https://doi.org/10.1007/s00726-021-03054-z
Shao A, Hathcock JN. Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regul Toxicol Pharmacol. 2008;50(3):376-99. DOI: https://doi.org/10.1016/j.yrtph.2008.01.004
Grimble GK. Adverse gastrointestinal effects of arginine and related amino acids. J Nutr. 2007;137:1693S-1701S. DOI: https://doi.org/10.1093/jn/137.6.1693S
Moinard C, Nicolis I, Neveux N, Darquy S, Bénazeth S, Cynober L. Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study. Br J Nutr. 2008;99(4):855-62. DOI: https://doi.org/10.1017/S0007114507841110
Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005;81(4):736-45. DOI: https://doi.org/10.1093/ajcn/81.4.736
Groeneveld GJ, Beijer C, Veldink JH, Kalmijn S, Wokke JHJ, Berg LH van den. Few Adverse Effects of Long-Term Creatine Supplementation in a Placebo-Controlled Trial. Int J Sports Med. 2004;26:307-13. DOI: https://doi.org/10.1055/s-2004-817917
Gale EA. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. The Lancet. 2004;363(9413):925-31. DOI: https://doi.org/10.1016/S0140-6736(04)15786-3
Hathcock JN, Shao A. Risk assessment for carnitine. Regul Toxicol Pharmacol RTP. 2006;46(1):23-8. DOI: https://doi.org/10.1016/j.yrtph.2006.06.007
Strzelecki D, Szyburska, Justyna, and Rabe-Jabłońska J. Two grams of sarcosine in schizophrenia – is it too much? A potential role of glutamate-serotonin interaction. Neuropsychiatr Dis Treat. 2014;10:263-6. DOI: https://doi.org/10.2147/NDT.S54024
Laaksonen M, Talala K, Martelin T, Rahkonen O, Roos E, Helakorpi S, et al. Health behaviours as explanations for educational level differences in cardiovascular and all-cause mortality: a follow-up of 60 000 men and women over 23 years. Eur J Public Health. 2008;18(1):38-43. DOI: https://doi.org/10.1093/eurpub/ckm051
Jandhyala R. Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument. Health Qual Life Outcomes. 2021;19(1):229. DOI: https://doi.org/10.1186/s12955-021-01862-1
Huynh TV, Rethi L, Lee TW, Higa S, Kao YH, Chen YJ. Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19. Cells. 2023;12(6):877. DOI: https://doi.org/10.3390/cells12060877
Clough E, Inigo J, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, et al. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J Neuroimmune Pharmacol. 2021;16(4):770-84. DOI: https://doi.org/10.1007/s11481-021-10015-6
Cao X, Nguyen V, Tsai J, Gao C, Tian Y, Zhang Y, et al. The SARS-CoV-2 spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice. Mol Metab. 2023;74:101756. DOI: https://doi.org/10.1016/j.molmet.2023.101756
Zekri-Nechar K, Zamorano-León JJ, Reche C, Giner M, López-de-Andrés A, Jiménez-García R, et al. Spike Protein Subunits of SARS-CoV-2 Alter Mitochondrial Metabolism in Human Pulmonary Microvascular Endothelial Cells: Involvement of Factor Xa. Dis Markers. 2022;2022(1):1118195. DOI: https://doi.org/10.1155/2022/1118195
Kim ES, Jeon MT, Kim KS, Lee S, Kim S, Kim DG. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells. Viruses. 2021;13(10):2021. DOI: https://doi.org/10.3390/v13102021
Yeung-Luk BH, Narayanan GA, Ghosh B, Wally A, Lee E, Mokaya M, et al. SARS-CoV-2 infection alters mitochondrial and cytoskeletal function in human respiratory epithelial cells mediated by expression of spike protein. mBio. 2023;14(4):e00820-23. DOI: https://doi.org/10.1128/mbio.00820-23
Charlton BT, Goulding RP, Jaspers RT, Appelman B, Vugt M van, Wüst RCI. Skeletal muscle adaptations and post-exertional malaise in long COVID. Trends Endocrinol Metab. 2024. Available at: https://www.cell.com/trends/endocrinology-metabolism/abstract/S1043-2760(24)00298-4. Accessed on 25 October 2025.
Meso Scale Diagnostics L. S-PLEX SARS-CoV-2 Spike Kit. Vols. 18249-v1-2021Jun. Rockville, MD: Meso Scale Diagnostics, LLC. 2021. Available at: www.mesoscale.com. Accessed on 25 October 2025.
Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009;39(8):495-501. DOI: https://doi.org/10.1111/j.1445-5994.2008.01880.x
Laskin JJ, Bundy S, Marron H, Moore H, Swanson M, Blair M, et al. Using a Treadmill for the 6-Minute Walk Test: RELIABILITY AND VALIDITY. J Cardiopulm Rehabil Prev. 2007;27(6):407. DOI: https://doi.org/10.1097/01.HCR.0000300270.45881.d0
da Silva ALG, Vieira L dos P, Dias LS, Prestes CV, Back GD, Goulart C da L, et al. Impact of long COVID on the heart rate variability at rest and during deep breathing maneuver. Sci Rep. 2023;13(1):22695. DOI: https://doi.org/10.1038/s41598-023-50276-0
Garmin, subsidiaries GL or its. Garmin HRM-DualTM | Heart Rate Monitor with Chest Strap. Garmin. Available at: https://www.garmin.com/en-CA/p/649059. Accessed on 25 October 2025.
Zamunér AR, Moreno MA, Camargo TM, Graetz JP, Rebelo ACS, Tamburús NY, et al. Assessment of Subjective Perceived Exertion at the Anaerobic Threshold with the Borg CR-10 Scale. J Sports Sci Med. 2011;10(1):130-6.
Downloads
Published
How to Cite
Issue
Section
